These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 35595812)

  • 1. Baseline serum Krebs von den Lungen-6 as a biomarker for the disease progression in idiopathic pulmonary fibrosis.
    Chung C; Kim J; Cho HS; Kim HC
    Sci Rep; 2022 May; 12(1):8564. PubMed ID: 35595812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood Krebs von den Lungen-6 levels predict treatment response to antifibrotic therapy in patients with idiopathic pulmonary fibrosis.
    Choi MG; Choi SM; Lee JH; Kim JY; Song JW
    Respir Res; 2022 Dec; 23(1):334. PubMed ID: 36494685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum Krebs von den Lungen-6 level predicts disease progression in interstitial lung disease.
    Ko UW; Cho EJ; Oh HB; Koo HJ; Do KH; Song JW
    PLoS One; 2020; 15(12):e0244114. PubMed ID: 33332430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surfactant protein A as a biomarker of outcomes of anti-fibrotic drug therapy in patients with idiopathic pulmonary fibrosis.
    Yoshikawa T; Otsuka M; Chiba H; Ikeda K; Mori Y; Umeda Y; Nishikiori H; Kuronuma K; Takahashi H
    BMC Pulm Med; 2020 Jan; 20(1):27. PubMed ID: 32005219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Characteristics and clinical significance of pulmonary function test and KL-6 in ASSD-ILD and IPF].
    Sun D; Cheng Z; Jiang TC; Li PF; Jia LQ; Wang TT; Zheng CP; Li Y; Duo MJ
    Zhonghua Yi Xue Za Zhi; 2020 Mar; 100(10):748-752. PubMed ID: 32192286
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical Research on Prognostic Evaluation of Subjects With IPF by Peripheral Blood Biomarkers, Quantitative Imaging Characteristics and Pulmonary Function Parameters.
    Guo L; Yang Y; Liu F; Jiang C; Yang Y; Pu H; Li W; Zhong Z
    Arch Bronconeumol (Engl Ed); 2020 Jun; 56(6):365-372. PubMed ID: 31740085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated serum Krebs von den Lungen-6 in systemic sclerosis: a marker of lung fibrosis and severity of the disease.
    Benyamine A; Heim X; Resseguier N; Bertin D; Gomez C; Ebbo M; Harlé JR; Kaplanski G; Rossi P; Bardin N; Granel B
    Rheumatol Int; 2018 May; 38(5):813-819. PubMed ID: 29455320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baseline plasma KL-6 level predicts adverse outcomes in patients with idiopathic pulmonary fibrosis receiving nintedanib: a retrospective real-world cohort study.
    Huang TH; Kuo CW; Chen CW; Tseng YL; Wu CL; Lin SH
    BMC Pulm Med; 2021 May; 21(1):165. PubMed ID: 33992083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of changes in the serum levels of Krebs von den Lungen-6 and surfactant protein-D over time as important biomarkers in idiopathic fibrotic nonspecific interstitial pneumonia.
    Yamakawa H; Hagiwara E; Ikeda S; Iwasawa T; Otoshi R; Tabata E; Okuda R; Sekine A; Baba T; Iso S; Okudela K; Takemura T; Ogura T
    Respir Investig; 2019 Sep; 57(5):422-429. PubMed ID: 31003951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Krebs von den Lungen-6 levels in untreated idiopathic pulmonary fibrosis.
    Jiang D; Xiao H; Dong R; Geng J; Xie B; Ren Y; Dai H
    Clin Respir J; 2022 Mar; 16(3):234-243. PubMed ID: 35081277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic role of Krebs von den Lungen-6 (KL-6) measurement in idiopathic pulmonary fibrosis: a systematic review and meta-analysis.
    Aloisio E; Braga F; Puricelli C; Panteghini M
    Clin Chem Lab Med; 2021 Jul; 59(8):1400-1408. PubMed ID: 33831978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the Diagnostic Efficacies of Serological Markers KL-6, SP-A, SP-D, CCL2, and CXCL13 in Idiopathic Interstitial Pneumonia.
    Xue M; Guo Z; Cai C; Sun B; Wang H
    Respiration; 2019; 98(6):534-545. PubMed ID: 31665737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Impact of Emphysema Evaluated by High-Resolution Computed Tomography on Idiopathic Pulmonary Fibrosis Diagnosed by Surgical Lung Biopsy.
    Kohashi Y; Arai T; Sugimoto C; Tachibana K; Akira M; Kitaichi M; Hayashi S; Inoue Y
    Respiration; 2016; 92(4):220-228. PubMed ID: 27576553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The usefulness of KL-6 and SP-D for the diagnosis and management of chronic hypersensitivity pneumonitis.
    Okamoto T; Fujii M; Furusawa H; Tsuchiya K; Miyazaki Y; Inase N
    Respir Med; 2015 Dec; 109(12):1576-81. PubMed ID: 26481343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Baseline KL-6 predicts increased risk for acute exacerbation of idiopathic pulmonary fibrosis.
    Ohshimo S; Ishikawa N; Horimasu Y; Hattori N; Hirohashi N; Tanigawa K; Kohno N; Bonella F; Guzman J; Costabel U
    Respir Med; 2014 Jul; 108(7):1031-9. PubMed ID: 24835074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of S100A9 and KL-6 in common interstitial lung diseases.
    Lin L; Zhao Y; Li Z; Li Y; Wang W; Kang J; Wang Q
    Medicine (Baltimore); 2022 Apr; 101(17):e29198. PubMed ID: 35512076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progression of Interstitial Lung Disease in Systemic Sclerosis: The Importance of Pneumoproteins Krebs von den Lungen 6 and CCL18.
    Volkmann ER; Tashkin DP; Kuwana M; Li N; Roth MD; Charles J; Hant FN; Bogatkevich GS; Akter T; Kim G; Goldin J; Khanna D; Clements PJ; Furst DE; Elashoff RM; Silver RM; Assassi S
    Arthritis Rheumatol; 2019 Dec; 71(12):2059-2067. PubMed ID: 31233287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative Study of Circulating MMP-7, CCL18, KL-6, SP-A, and SP-D as Disease Markers of Idiopathic Pulmonary Fibrosis.
    Hamai K; Iwamoto H; Ishikawa N; Horimasu Y; Masuda T; Miyamoto S; Nakashima T; Ohshimo S; Fujitaka K; Hamada H; Hattori N; Kohno N
    Dis Markers; 2016; 2016():4759040. PubMed ID: 27293304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Importance of serial changes in biomarkers in idiopathic pulmonary fibrosis.
    Sokai A; Tanizawa K; Handa T; Kanatani K; Kubo T; Ikezoe K; Nakatsuka Y; Tokuda S; Oga T; Hirai T; Nagai S; Chin K; Mishima M
    ERJ Open Res; 2017 Jul; 3(3):. PubMed ID: 28875146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated serum human epididymis protein 4 is associated with disease severity and worse survival in idiopathic pulmonary fibrosis: a cohort study.
    Tian M; Meng K; Gao Y; Zhang J; Xie M; Tian Y; Liu X; Ma M; Cai Y; Wu H; Ding J; Chen J; Cai H
    Ann Transl Med; 2022 Sep; 10(18):992. PubMed ID: 36267722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.